Which has stronger earnings and valuation, PEN or LNTH?

Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.45B 8.64 $177.69M $4.34 73.61 Lantheus $1.54B 4.25 $233.56M $4.15 24.25

Is PEN or LNTH more profitable?

Lantheus has a net margin of 18.05% compared to Penumbra's net margin of 11.76%. Lantheus' return on equity of 29.32% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 11.76% 10.87% 8.45% Lantheus 18.05% 29.32% 15.00%

Does the media prefer PEN or LNTH?

In the previous week, Lantheus had 4 more articles in the media than Penumbra. MarketBeat recorded 6 mentions for Lantheus and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat Lantheus' score of 0.46 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lantheus 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, PEN or ITGR?

Penumbra has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.45B 8.64 $177.69M $4.34 73.61 Integer $1.85B 1.67 $102.81M $4.01 22.75

Is PEN or ITGR more profitable?

Penumbra has a net margin of 11.76% compared to Integer's net margin of 7.64%. Integer's return on equity of 12.83% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 11.76% 10.87% 8.45% Integer 7.64% 12.83% 6.51%

Does the media prefer PEN or ITGR?

In the previous week, Penumbra and Penumbra both had 2 articles in the media. Penumbra's average media sentiment score of 1.19 beat Integer's score of -0.27 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, PEN or MDLN?

Penumbra has higher earnings, but lower revenue than Medline. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.45B 8.64 $177.69M $4.34 73.61 Medline $28.43B 1.57 N/A N/A N/A

Is PEN or MDLN more profitable?

Penumbra has a net margin of 11.76% compared to Medline's net margin of 0.00%. Penumbra's return on equity of 10.87% beat Medline's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 11.76% 10.87% 8.45% Medline N/A N/A N/A

Does the media refer more to PEN or MDLN?

In the previous week, Medline had 7 more articles in the media than Penumbra. MarketBeat recorded 9 mentions for Medline and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat Medline's score of 0.57 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medline 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PEN or GEHC?

In the previous week, GE HealthCare Technologies had 13 more articles in the media than Penumbra. MarketBeat recorded 15 mentions for GE HealthCare Technologies and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat GE HealthCare Technologies' score of 1.04 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer PEN or PHG?

Penumbra presently has a consensus price target of $361.33, suggesting a potential upside of 13.11%. Given Penumbra's stronger consensus rating and higher probable upside, analysts plainly believe Penumbra is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 14 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18 Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer PEN or PHG?

In the previous week, Koninklijke Philips had 1 more articles in the media than Penumbra. MarketBeat recorded 3 mentions for Koninklijke Philips and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat Koninklijke Philips' score of 0.20 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Penumbra (PEN) Competitors

$319.53 +0.79 (+0.25%)

As of 02:50 PM Eastern

Compare

PEN vs. LNTH, ITGR, MDLN, GEHC, and PHG

Should you buy Penumbra stock or one of its competitors? MarketBeat compares Penumbra with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Penumbra include Lantheus (LNTH), Integer (ITGR), Medline (MDLN), GE HealthCare Technologies (GEHC), and Koninklijke Philips (PHG).

How does Penumbra compare to Lantheus?

Penumbra (NYSE:PEN) and Lantheus (NASDAQ:LNTH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Penumbra has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market. Comparatively, Lantheus has a beta of -0.03, indicating that its stock price is 103% less volatile than the broader market.

Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.64	$177.69M	$4.34	73.61
Lantheus	$1.54B	4.25	$233.56M	$4.15	24.25

88.9% of Penumbra shares are owned by institutional investors. Comparatively, 99.1% of Lantheus shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Comparatively, 1.7% of Lantheus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Lantheus has a net margin of 18.05% compared to Penumbra's net margin of 11.76%. Lantheus' return on equity of 29.32% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
Lantheus	18.05%	29.32%	15.00%

In the previous week, Lantheus had 4 more articles in the media than Penumbra. MarketBeat recorded 6 mentions for Lantheus and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat Lantheus' score of 0.46 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lantheus	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Penumbra currently has a consensus price target of $361.33, suggesting a potential upside of 13.11%. Lantheus has a consensus price target of $101.86, suggesting a potential upside of 1.20%. Given Penumbra's higher probable upside, analysts clearly believe Penumbra is more favorable than Lantheus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Lantheus	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Lantheus beats Penumbra on 9 of the 16 factors compared between the two stocks.

How does Penumbra compare to Integer?

Penumbra (NYSE:PEN) and Integer (NYSE:ITGR) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Penumbra has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.64	$177.69M	$4.34	73.61
Integer	$1.85B	1.67	$102.81M	$4.01	22.75

88.9% of Penumbra shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 2.9% of Penumbra shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Penumbra has a net margin of 11.76% compared to Integer's net margin of 7.64%. Integer's return on equity of 12.83% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
Integer	7.64%	12.83%	6.51%

In the previous week, Penumbra and Penumbra both had 2 articles in the media. Penumbra's average media sentiment score of 1.19 beat Integer's score of -0.27 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Penumbra presently has a consensus target price of $361.33, suggesting a potential upside of 13.11%. Integer has a consensus target price of $98.71, suggesting a potential upside of 8.22%. Given Penumbra's higher possible upside, equities analysts plainly believe Penumbra is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27

Penumbra has a beta of 0.71, indicating that its share price is 29% less volatile than the broader market. Comparatively, Integer has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market.

Summary

Penumbra beats Integer on 10 of the 15 factors compared between the two stocks.

How does Penumbra compare to Medline?

Penumbra (NYSE:PEN) and Medline (NASDAQ:MDLN) are both large-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

Penumbra presently has a consensus price target of $361.33, suggesting a potential upside of 13.11%. Medline has a consensus price target of $50.54, suggesting a potential upside of 48.61%. Given Medline's stronger consensus rating and higher probable upside, analysts clearly believe Medline is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Medline	1 Sell rating(s)	5 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.79

88.9% of Penumbra shares are held by institutional investors. 2.9% of Penumbra shares are held by company insiders. Comparatively, 0.8% of Medline shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Medline had 7 more articles in the media than Penumbra. MarketBeat recorded 9 mentions for Medline and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat Medline's score of 0.57 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medline	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Penumbra has a net margin of 11.76% compared to Medline's net margin of 0.00%. Penumbra's return on equity of 10.87% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
Medline	N/A	N/A	N/A

Penumbra has higher earnings, but lower revenue than Medline.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.64	$177.69M	$4.34	73.61
Medline	$28.43B	1.57	N/A	N/A	N/A

Summary

Penumbra beats Medline on 7 of the 13 factors compared between the two stocks.

How does Penumbra compare to GE HealthCare Technologies?

Penumbra (NYSE:PEN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

In the previous week, GE HealthCare Technologies had 13 more articles in the media than Penumbra. MarketBeat recorded 15 mentions for GE HealthCare Technologies and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat GE HealthCare Technologies' score of 1.04 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GE HealthCare Technologies	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Penumbra has a beta of 0.71, indicating that its share price is 29% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.

Penumbra has a net margin of 11.76% compared to GE HealthCare Technologies' net margin of 9.10%. GE HealthCare Technologies' return on equity of 20.46% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
GE HealthCare Technologies	9.10%	20.46%	5.73%

GE HealthCare Technologies has higher revenue and earnings than Penumbra. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.64	$177.69M	$4.34	73.61
GE HealthCare Technologies	$20.98B	1.34	$2.08B	$4.18	14.82

88.9% of Penumbra shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Penumbra presently has a consensus target price of $361.33, suggesting a potential upside of 13.11%. GE HealthCare Technologies has a consensus target price of $80.21, suggesting a potential upside of 29.52%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Penumbra and GE HealthCare Technologies tied by winning 8 of the 16 factors compared between the two stocks.

How does Penumbra compare to Koninklijke Philips?

Penumbra (NYSE:PEN) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

Penumbra presently has a consensus price target of $361.33, suggesting a potential upside of 13.11%. Given Penumbra's stronger consensus rating and higher probable upside, analysts plainly believe Penumbra is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Koninklijke Philips had 1 more articles in the media than Penumbra. MarketBeat recorded 3 mentions for Koninklijke Philips and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat Koninklijke Philips' score of 0.20 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Koninklijke Philips has higher revenue and earnings than Penumbra. Koninklijke Philips is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.64	$177.69M	$4.34	73.61
Koninklijke Philips	$17.64B	1.38	$1.01B	$1.17	21.65

Penumbra has a net margin of 11.76% compared to Koninklijke Philips' net margin of 5.49%. Koninklijke Philips' return on equity of 13.51% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
Koninklijke Philips	5.49%	13.51%	5.48%

Penumbra has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

88.9% of Penumbra shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Penumbra beats Koninklijke Philips on 11 of the 16 factors compared between the two stocks.

Get Penumbra News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PEN vs. The Competition

Export

Metric	Penumbra	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$12.56B	$7.02B	$6.26B	$23.14B
Dividend Yield	N/A	1.21%	2.69%	4.09%
P/E Ratio	73.57	45.10	22.42	31.05
Price / Sales	8.64	86.58	548.01	14.78
Price / Cash	74.19	24.40	42.31	24.78
Price / Book	8.76	7.12	9.82	4.68
Net Income	$177.69M	$159.22M	$3.56B	$1.07B
7 Day Performance	-0.40%	0.51%	-1.17%	-0.46%
1 Month Performance	-1.89%	3.57%	3.71%	0.43%
1 Year Performance	24.14%	0.57%	27.28%	25.81%

Penumbra Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PEN Penumbra	2.1736 of 5 stars	$319.45 +0.2%	$361.33 +13.1%	+24.2%	$12.56B	$1.45B	73.57	4,700	Positive News
LNTH Lantheus	2.2554 of 5 stars	$103.00 flat	$99.71 -3.2%	+24.9%	$6.71B	$1.54B	24.82	1,193
ITGR Integer	1.7218 of 5 stars	$89.34 +0.1%	$98.29 +10.0%	-23.4%	$3.03B	$1.85B	22.28	11,000
MDLN Medline	3.7783 of 5 stars	$37.01 flat	$50.85 +37.4%	N/A	$48.62B	$28.43B	N/A	43,000	Analyst Forecast High Trading Volume
GEHC GE HealthCare Technologies	4.9349 of 5 stars	$64.23 flat	$80.21 +24.9%	-11.6%	$29.22B	$20.63B	15.37	54,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PEN) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Penumbra (PEN) Competitors